Methyl 1-(4-chlorophenyl)-3-oxocyclobutane-1-carboxylate, 97%, 5g

N-(3-pyridinylmethyl)quinuclidin-3-amine triethanedioate, 95.0%, 25g

Ru(OAc)2[(R)-xylbinap]200mg

2-methyl-1-(pentan-2-yl)piperazine, 95.0%, 2g

(1R,3R,4R,7S)-1-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2,5-dioxabicyclo[2.2.1]heptan-7-yl (2-cyanoethyl) diisopropylphosphoramidite, 98%, 100mg

4-Fluorophenyl Methyl Sulfone>98.0%(GC)25g

2-Pentanethiol, 25g

5-Bromo-2-fluoro-N-methylbenzenamine, 98%, 5g

5-Bromo-4-cyclopropyl-6-methoxypyrimidine, 97%, 250mg

6-(Pyridin-4-yl)benzo[d]thiazol-2-amine, 98%, 500mg

2,6-Dibromotoluene, 98.0%, 100g

Microliter syringe MICROLITER® series 7000 Point type 3, 5.0 µl, 7105 KH, 1 piece

(2-(Piperidin-1-yl)phenyl)methanamine, 95.0%, 250mg